Moderna’s RSV shot 83.7% effective, late-stage trial shows
By Paige Twentier for Becker’s Hospital Review on January 18, 2023 Moderna’s respiratory syncytial virus vaccine candidate for older adults
Read MoreBy Paige Twentier for Becker’s Hospital Review on January 18, 2023 Moderna’s respiratory syncytial virus vaccine candidate for older adults
Read MoreBy Judith Graham on January 18, 2023 for Kaiser Health News A new coronavirus variant is circulating, the most transmissible
Read More(By Helen Branswell for STAT) It’s like clockwork now. Every few months, we’re warned that the Omicron variant of the
Read More(By Erica Carbajal for Becker’s Hospital Review) Health officials are keeping a close eye on omicron subvariant XBB.1.5 due to
Read MoreBy Selena Simmons-Duffin for NPR on December 28, 2022 The U.S. has come a long way from two years ago
Read MoreBy Helen Branswell for Stat News on December 27, 2022 People who study infectious diseases and who work in public
Read More(By Priya Chidambaram and Alice Burns for The Kaiser Family Foundation Published: Dec 12, 2022) Moving into the holiday—and COVID-19/flu
Read More(By Nika Schoonover for Becker’s Hospital Review) Adults who were prescribed Paxlovid for mild to moderate COVID-19 were 50 percent
Read More(By Hannah Recht for Kaiser Health News) Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal
Read More(By Blake Farmer for NPR) Medical equipment is still strewn around the house of Rick Lucas, 62, who came home
Read More